http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114409631-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_180f7c58622a8c001dcd79281ef831c9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 2022-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_529ec7e02b114da5b23b21dc080d395f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_619a09427dc14379d090b095d7eecce4
publicationDate 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114409631-A
titleOfInvention Preparation method of esomeprazole impurity H431/41
abstract The invention discloses a preparation method of an esomeprazole impurity H431/41, which comprises the following steps: esomeprazole is degraded by hydrochloric acid at room temperature (20-25 ℃) to generate 8- (or 9-) methoxy-1, 3-dimethyl-12-thiopyrido [1,2:3,4] -imidazo [1,2-a ] benzimidazol-2 (12H) -one, and then alkaline hydrolysis is carried out to generate esomeprazole impurity H431/41. The invention has simple reaction route, does not relate to the reaction under harsh chemical reaction conditions, does not relate to high-risk chemical reaction process, and is suitable for laboratory trial production of impurity reference substances.
priorityDate 2022-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450645223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9579578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408176483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426076236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665647
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415800821

Total number of triples: 40.